» Articles » PMID: 24975905

Phenotypic Spectrum of Heart Failure with Preserved Ejection Fraction

Overview
Journal Heart Fail Clin
Date 2014 Jul 1
PMID 24975905
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome, with several underlying etiologic and pathophysiologic factors. The heterogeneity of the HFpEF syndrome may explain why (1) diagnosing and treating HFpEF is so challenging and (2) clinical trials in HFpEF have failed thus far. Here we describe 4 ways of categorizing HFpEF based on pathophysiology, clinical/etiologic subtype, type of clinical presentation, and quantitative phenomics (phenomapping analysis). Regardless of the classification method used, improved phenotypic characterization of HFpEF, and matching targeted therapies with specific HFpEF subtypes, will be a critical step towards improving outcomes in this increasingly prevalent syndrome.

Citing Articles

Mechanisms of exercise intolerance in hear-t failure with preserved ejection fraction (HFpEF).

Pecchia B, Samuel R, Shah V, Newman E, Gibson G Heart Fail Rev. 2025; .

PMID: 40080287 DOI: 10.1007/s10741-025-10504-3.


Housing temperature influences metabolic phenotype of heart failure with preserved ejection fraction in J vs N strain C57BL/6 mice.

Chaudhary R, Suhan T, Wu C, Alzamrooni A, Madamanchi N, Abdel-Latif A Mol Cell Endocrinol. 2025; 598:112457.

PMID: 39788312 PMC: 11820722. DOI: 10.1016/j.mce.2025.112457.


Diagnostic and therapeutic practice for HFpEF across continents and regions: An international survey.

Ingimarsdottir I, Vishram-Nielsen J, Einarsson H, Goldfeder S, Mewton N, Barasa A ESC Heart Fail. 2024; 12(1):487-496.

PMID: 39351634 PMC: 11769610. DOI: 10.1002/ehf2.15084.


The Icelandic Heart Failure Registry-A nationwide assessment tool for HF care and intervention in HF treatment.

Ingimarsdottir I, Hansen J, Bergmann H, Einarsson H ESC Heart Fail. 2024; 11(6):4081-4091.

PMID: 39104306 PMC: 11631331. DOI: 10.1002/ehf2.15012.


Exploring Sirtuins: New Frontiers in Managing Heart Failure with Preserved Ejection Fraction.

Lu Y, Li Y, Xie Y, Bu J, Yuan R, Zhang X Int J Mol Sci. 2024; 25(14).

PMID: 39062982 PMC: 11277469. DOI: 10.3390/ijms25147740.


References
1.
Shah S . Evolving approaches to the management of heart failure with preserved ejection fraction in patients with coronary artery disease. Curr Treat Options Cardiovasc Med. 2010; 12(1):58-75. DOI: 10.1007/s11936-009-0060-2. View

2.
Lam C, Roger V, Rodeheffer R, Borlaug B, Enders F, Redfield M . Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol. 2009; 53(13):1119-26. PMC: 2736110. DOI: 10.1016/j.jacc.2008.11.051. View

3.
Zile M, Baicu C, Gaasch W . Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med. 2004; 350(19):1953-9. DOI: 10.1056/NEJMoa032566. View

4.
Shah A, Solomon S . Phenotypic and pathophysiological heterogeneity in heart failure with preserved ejection fraction. Eur Heart J. 2012; 33(14):1716-7. DOI: 10.1093/eurheartj/ehs124. View

5.
Prasad A, Hastings J, Shibata S, Popovic Z, Arbab-Zadeh A, Bhella P . Characterization of static and dynamic left ventricular diastolic function in patients with heart failure with a preserved ejection fraction. Circ Heart Fail. 2010; 3(5):617-26. PMC: 3716372. DOI: 10.1161/CIRCHEARTFAILURE.109.867044. View